| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 99,465 | 138,643 | 137,974 | 152,377 | | Cost of Revenue | 4,801 | 5,605 | 6,847 | 7,021 | | | Gross Profit |
-
| 133,038 | 131,127 | 145,356 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 79,807 | 89,012 | 83,048 | 65,333 | | Non Recurring |
-
|
-
| 4,092 | (3,503) | | Others | (34,798) | 29,176 | 78,511 | 80,785 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 14,850 | (34,524) | 2,741 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 49,655 | 14,850 | (34,524) | 21,880 | | Interest Expense | 6,367 | 7,270 | 8,181 | 9,694 | | Income Before Tax | 43,288 | 7,580 | (42,705) | 12,186 | | Income Tax Expense | 16,879 | 6,428 | (1,702) | 2,319 | | Minority Interest | 40,708 | (33,993) | 33,993 | 11,694 | | | | Net Income From Continuing Ops | 67,117 | (32,841) | (7,010) | 2,422 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 67,117 | (32,841) | (7,010) | 2,422 | | Preferred Stock And Other Adjustments | (53,590) | 46,490 | (3,536) | (707) | | | Net Income Applicable To Common Shares | $13,527 | $13,649 | ($10,546) | $1,715 |
|
0.24% Nasdaq 
0.55%
Income Statement
